Rare Blood Clots Prompt Pause Of J&J COVID Vaccine
Federal health officials on Tuesday recommended a pause in the administration of Johnson & Johnson's single-dose COVID-19 vaccine pending a review of six U.S. cases of rare and serious blood clots...To view the full article, register now.
Already a subscriber? Click here to view full article